Stay updated on Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A banner announces NIH website transition updates and says that “Super Intelligence” may appear in place of “Artificial Intelligence” across NIH content.
    Difference
    1%
    Check dated 2026-10-21T17:44:28.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.1 to v3.7.2. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-14T17:08:48.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.0 to v3.7.1, while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T17:52:39.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error with a minimal header and a Home link. Most study-related content and navigational elements are absent on this page, indicating the record is not currently accessible.
    Difference
    20%
    Check dated 2026-09-23T20:55:54.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision updated from v3.6.6 to v3.7.0, indicating a new version of the page. The update represents a metadata refresh rather than a change to study information.
    Difference
    0.1%
    Check dated 2026-09-16T22:05:34.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.5 to v3.6.6, representing a minor update to the page's version information.
    Difference
    0.1%
    Check dated 2026-09-02T19:59:08.000Z thumbnail image

Stay in the know with updates to Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial page.